Top Hospitals for Lung Cancer Treatment in the USA (2026)

A lung cancer diagnosis moves fast, and where you get treated can meaningfully affect your outcome. Lung cancer care isn’t one-size-fits-all — the right hospital should offer advanced diagnostics, minimally invasive thoracic surgery, access to targeted therapy and immunotherapy, and a multidisciplinary team that includes pulmonologists, thoracic surgeons, medical oncologists, and radiation oncologists working together. Below is a data-driven look at the top U.S. hospitals for lung cancer treatment in 2026, based on the newly released U.S. News & World Report 2026–2027 specialty rankings.

Top-Ranked Hospitals for Pulmonology & Lung Surgery (2026–2027)

U.S. News evaluates hospitals nationally for Pulmonology & Lung Surgery — the specialty ranking most directly relevant to lung cancer treatment, since it covers thoracic surgery, complex respiratory conditions, and lung cancer surgical outcomes specifically. The top five hospitals in the country for 2026–2027 are:

  1. UCSF Health–UCSF Medical Center — San Francisco, CA
  2. NYU Langone Hospitals — New York, NY
  3. Mayo Clinic — Rochester, MN
  4. Northwestern Medicine–Northwestern Memorial Hospital — Chicago, IL
  5. UCLA Ronald Reagan Medical Center — Los Angeles, CA

NYU Langone had held the No. 1 spot for the two prior years running, so UCSF’s move to the top this cycle reflects the impact of this year’s heavier weighting toward risk-adjusted outcomes. Other institutions that consistently rank in the national top 10 for this specialty include Cedars-Sinai Medical Center, Cleveland Clinic, and Massachusetts General Hospital.

What Makes These Hospitals Stand Out for Lung Cancer Specifically

Beyond the overall pulmonology ranking, U.S. News also rates hospitals separately on lung cancer surgery outcomes, using data like patient survival rates, ability to recover at home, procedure volume, and cancer-specific accreditation. Hospitals that consistently earn a “High Performing” rating in lung cancer surgery include NYU Langone, Mayo Clinic–Rochester, UCLA Medical Center, and Cedars-Sinai Medical Center.

For lung cancer patients, it’s also worth looking beyond the pulmonology ranking toward NCI-Designated Comprehensive Cancer Centers, since these programs combine surgical expertise with cutting-edge systemic treatment and clinical trial access. Leading comprehensive cancer centers with major thoracic oncology programs include:

  • MD Anderson Cancer Center — Houston, TX
  • Memorial Sloan Kettering Cancer Center — New York, NY
  • Dana-Farber Brigham Cancer Center — Boston, MA
  • Cleveland Clinic — Cleveland, OH
  • Mayo Clinic–Rochester — Rochester, MN

These centers are especially valuable for advanced or metastatic lung cancer, where treatment often involves targeted molecular therapy, immunotherapy, or enrollment in clinical trials not available at community hospitals.

Key Factors When Choosing a Lung Cancer Treatment Center

Rankings are a useful starting point, but a few specific factors matter more for lung cancer than for many other conditions:

  • Multidisciplinary tumor boards. Top centers review complex cases with a team spanning surgery, oncology, radiology, and pathology — this often changes the recommended treatment plan.
  • Minimally invasive surgical options. Ask whether the center offers video-assisted thoracoscopic surgery (VATS) or robotic-assisted lobectomy, which generally mean faster recovery than open surgery.
  • Biomarker testing capability. For non-small cell lung cancer especially, testing for mutations like EGFR, ALK, and KRAS can open up targeted therapies — confirm the hospital runs comprehensive genomic testing in-house.
  • Clinical trial access. Academic and NCI-designated centers typically offer far more active lung cancer trials than community hospitals, which matters most for advanced-stage disease.
  • Procedure volume. Higher-volume thoracic surgery programs are consistently linked to better surgical outcomes and fewer complications.
  • Second opinions. Given how much staging and molecular findings can shift a treatment plan, a second opinion at a high-volume center is often worthwhile even if your primary treatment happens closer to home.

The Bottom Line

For lung cancer care, the strongest combination is a hospital with both a top-ranked pulmonology and thoracic surgery program and deep cancer-specific infrastructure — genomic testing, tumor boards, and trial access. UCSF, NYU Langone, Mayo Clinic, Northwestern Memorial, and UCLA lead the national pulmonology rankings this year, while NCI-designated centers like MD Anderson and Memorial Sloan Kettering remain go-to destinations for complex or advanced cases. Talk with your care team about staging and treatment goals first — that conversation should drive which type of center makes the most sense for you.

Rankings referenced from U.S. News & World Report’s 2026–2027 Best Hospitals for Pulmonology & Lung Surgery, released August 2026.

Leave a Comment